Incidences, Causes, and Outcomes of Febrile Illness in Rural South and Southeast Asia
NCT ID: NCT04478578
Last Updated: 2024-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100000 participants
OBSERVATIONAL
2021-08-04
2024-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
This study is funded by the UK Wellcome Trust. The grant reference number is 215604/Z/19/Z
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Causes and Outcomes of Febrile Illness in Health Facilities in Rural South and Southeast Asia
NCT04629053
Improving Care Through Azithromycin Research for Infants in Africa
NCT04235816
Laos Out-Of-Pocket Costs: an Observational Study on the Impact of Severe Childhood Illness on the Health, Wealth and Wellbeing of Household Members in Laos
NCT05239104
Causes of Fever in Bangladeshi Patients
NCT02339259
Understanding Paratyphoid Infection
NCT02100397
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with febrile illness
Participants from approximately 650 villages, with a target number of 100,000 episodes of febrile illness, will be enrolled into this study.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willingness and ability to comply with study protocol for the study duration.
* Written informed consent given to participate in the trial.
Exclusion Criteria
* Accident or trauma is the cause for presentation
* Presentation ≤ 3 days after routine immunisations
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical Action Myanmar
OTHER
Shoklo Malaria Research Unit
OTHER
Lao-Oxford-Mahosot Hospital Wellcome Trust Research Unit
OTHER
Building Resources Across Communities (BRAC), Bangladesh
UNKNOWN
Mahidol Oxford Tropical Medicine Research Unit
OTHER
Action for Health Development (AHEAD)
UNKNOWN
University of Oxford
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yoel Lubell, Prof
Role: PRINCIPAL_INVESTIGATOR
Mahidol Oxford Tropical Medicine Research Unit
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Building Resources Across Communities (BRAC)
Dhaka, , Bangladesh
Medical Action Myanmar (MAM)
Yangon, , Burma
Action for Health Development (AHEAD)
Battambang, , Cambodia
Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LOMWRU)
Vientiane, Vientiane Prefecture, Laos
Mahidol VivaResearch Unit, Faculty of Tropical Medicine, Mahidol University (MVRU)
Ratchathewi, Bangkok, Thailand
Shoklo Malaria Research Unit (SMRU)
Mae Sot, Changwat Tak, Thailand
Chiangrai Clinical Research Unit (CCRU)
Chiang Rai, , Thailand
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BAC20001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.